Stocktoria

Beta Bionics, Inc. BBNX

Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2025-01-30

Beta Bionics, Inc. statistics & valuation

Market cap$749.5M
P / S7.5×
P / B2.6×
Net margin-73.0%
Return on equity-25.5%
FCF margin-56.1%
Return on capital-24.1%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-367.60% -84.10% -73.00% 202320242025
Gross margin (%)
52.60% 55.10% 55.40% 202320242025
Operating margin (%)
-298.90% -69.50% -71.50% 202320242025
Return on equity (%)
-25.50% 202320242025
Shares outstanding
5.3M 6.7M 44.4M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-40.10% -36.60% -22.30% 202320242025
Free cash flow margin (%)
-273.80% -79.30% -56.10% 202320242025
Debt / equity (×)
202320242025
EPS ($)
-$8.31 -$8.60 -$1.81 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Gross margin55.4%55.1%52.6%
Operating margin-71.5%-69.5%-298.9%
Net margin-73.0%-84.1%-367.6%
FCF margin-56.1%-79.3%-273.8%
Return on assets-22.3%-36.6%-40.1%
Return on equity-25.5%22.3%21.7%
Current ratio8.666.299.77

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.